Sat, Dec 21, 2024
[Archive]
Volume 16, Issue 3 (September 2024 2024)
Iranian Journal of Blood and Cancer 2024, 16(3): 48-54 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Davoudi Kiakalayeh A, Darbandi B, Davoudi-kiakalayeh S. Mapping of Favism and G6PD Disease in Iran: A Mini Review. Iranian Journal of Blood and Cancer 2024; 16 (3) :48-54
URL: http://ijbc.ir/article-1-1574-en.html
URL: http://ijbc.ir/article-1-1574-en.html
1- Department of Preventive and Social Medicine, School of Medicine, Guilan University of Medical Sciences. Rasht, Iran. , davoudikiakalayeh@gmail.com
2- Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
3- Trauma Institute, Guilan University of Medical Sciences. Rasht, Iran.
2- Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
3- Trauma Institute, Guilan University of Medical Sciences. Rasht, Iran.
Abstract: (177 Views)
Hemolytic illness an interaction with Vicia fava, also referred to as fava beans, results in favism. This contact can happen in a few different ways: eating raw, cooked, or dried beans; walking through fields where V. fava is grown and possibly breathing in pollen; and introducing fava beans to a breastfed baby through their mother's milk. In populations, the illness is common. For example, it's typical to walk through fields that have been planted with fava in the northern Iranian provinces of Mazandaran and Guilan. This is a problem in areas where thalassemia is common since patients there frequently need blood transfusions. Although favism has a considerable economic impact, there is a limited number of particular statistics on this matter. This paper explores the implications of recent findings on favism and G6PD for the future.
: Mini Review |
Subject:
Pediatric Hematology & Oncology
Received: 2024/06/21 | Accepted: 2024/09/13 | Published: 2024/09/30
Received: 2024/06/21 | Accepted: 2024/09/13 | Published: 2024/09/30
References
1. Vogels IM, Van Noorden CJ, Wolf BH, Saelman DE, Tromp A, Schutgens RB, Weening RS. Cytochemical determination of heterozygous glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Br J Haematol 1986; 63(2):402-5. [DOI:10.1111/j.1365-2141.1986.tb05570.x]
2. Shah SS, Diakite SA, Traore K, Diakite M, Kwiatkowski DP, Rockett KA, et al. A novel cytofluorometric assay for the detection and quantification of glucose6-phosphate dehydrogenase deficiency. Sci Rep 2012; 2:299. [DOI:10.1038/srep00299]
3. Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G, et al. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J 1986;5(8):1849-55. [DOI:10.1002/j.1460-2075.1986.tb04436.x]
4. Arese P, Mannuzzu L, Turrini F. Pathophysiology of favism. Folia Haematol Int Mag Klin Morphol Blutforsch 1989;116(5):745-52.
5. Caballero B, Food Intolerance, Encyclopedia of Human Nutrition. Third Edition, December 28, 2012. [DOI:10.1016/B978-0-12-821848-8.10114-3]
6. Arese P, De Flora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 1990; 27(1):1-40.
7. Cardador-Martinez A, Maya-Ocana K, Ortiz-Moreno A, et al. Effect of roasting and boiling on the content of vicine, convicine and L-3,4-dihydroxyphenylalanine in Vicia faba L. J Food Qual 2012;35:419-428. [DOI:10.1111/jfq.12006]
8. Pulkkinen M, Zhou X, Lampi AM, Piironen V. Determination and stability of divicine and isouramil produced by enzymatic hydrolysis of vicine and convicine of faba bean. Food Chem 2016; 212:10-9. [DOI:10.1016/j.foodchem.2016.05.077]
9. Nagalla S. Besa EC, et al. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency. Med scape. Jul 19, 2021. Available from: URL: https://emedicine.medscape.com/article/200390-overview?form=fpf
10. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map. PLOS MEDICINE. 2012;9(11): e1001339. [DOI:10.1371/journal.pmed.1001339]
11. Lauden SM, Chongwain S, Achidi A, Helm E, Cusick SE, Krug A, et al. Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors. BMC Research Notes 2019; 12(1): 195. [DOI:10.1186/s13104-019-4226-z]
12. World Health Organization. Technical Consultation to Review the Classification of Glucose-6-Phosphate Dehydrogenase (G6PD). 25 & 27 January 2022, virtual meeting. Available online: https://cdn.who.int/media/docs/ (accessed on 18 July 2022).
13. Salvati AM, Maffi D, Caprari P, Pasquino MT, Caforio MP, Tarzia A. Glucose-6-phosphate dehydrogenase deficiency and haemolytic agents. Ann. Ist. Super. Sanità .1999;35: 193-203.
14. Luzzatto L, Nannelli C, Notaro R. Glucose-6-Phosphate Dehydrogenase Deficiency. Hematol. Oncol. Clin 2016;30(2): 373-393. [DOI:10.1016/j.hoc.2015.11.006]
15. Hwang DF, Chen TU, Toxins in Food: Naturally Occurring. Encyclopedia of Food and Health. 2016. [DOI:10.1016/B978-0-12-384947-2.00698-X]
16. Karkanis A, Ntatsi G, Lepse L, Fernández JA, Vågen IM , Rewald B , et al. Faba Bean Cultivation - Revealing Novel Managing Practices for More Sustainable and Competitive European Cropping Systems. Front. Plant Sci. 02 August 2018(9) :1115. [DOI:10.3389/fpls.2018.01115]
17. Nelson DL, Cox MM. Lehninger Principles of Biochemistry (6th ed.). Basingstoke, England: Macmillan Higher Education. 13 February 2013. p. 576. ISBN 978-1-4641-0962-1.
18. Huheey JE, Martin DL. Malaria, favism and glucose-6-phosphate dehydrogenase deficiency. Experientia 1975; 31(10):1145-7. [DOI:10.1007/BF02326760]
19. Allahverdiyev AM, Bagirova M, Elcicek S, Cakir Koc R, Ates SC, SY Baydar, et al. Glucose-6-Phosphate Dehydrogenase Deficiency and Malaria: A Method to Detect Primaquine-Induced Hemolysis in vitro, intechopen.com. November 14th, 2012. DOI: 10.5772/48403 [DOI:10.5772/48403]
20. Arese P. How genetics and biology helped humanity to survive falciparum malaria Parassitologia 2006; 48(4):553-559.
21. Mbanefo EC, Ahmed AM, Titouna A, Elmaraezy A,Trang NT, Phuoc Long N, et al. Association of glucose-6-phosphate dehydrogenase deficiency and malaria: A systematic review and meta-analysis Scientific Reports. 2017; 7: p. 45963. [DOI:10.1038/srep45963]
22. Donoso G, Hedayat H, and Khayatian H. Favism, with special reference to Iran. Bull World Health Organ. 1969; 40(4): 513-519.
23. Beretta A, Manuelli M, Cena H, Favism: Clinical Features at Different Ages. Nutrients. 2023; 15(2): 343. [DOI:10.3390/nu15020343]
24. Meletis J, Konstantopoulos K. Favism - From the "avoid fava beans" of Pythagoras to the present. HAEMA 2004; 7(1):17.
25. Diegues A , Simões P , Ceriz T , Lopes A, Tomé E. Favism: A Case Report. Cureus. 2022; 14(3): e23269. [DOI:10.7759/cureus.23269]
26. Hsia YE, Miyakawa F, Baltazar J, Ching NS, Yuen J, Westwood B, et al. Frequency of glucose-6-phosphate dehydrogenase (G6PD) mutations in Chinese, Filipinos, and Laotians from Hawaii. Hum Genet 1993 Nov;92(5):470-6. [DOI:10.1007/BF00216453]
27. Jamerson BD , Haryadi TH, Bohannon A. Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19? Archives of Medical Research . Volume 51, Issue 7, October 2020, Pages 743-744. [DOI:10.1016/j.arcmed.2020.06.006]
28. Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007 Sep;21(5):267-83. doi: 10.1016/j.blre.2007.05.002. Epub 2007 Jul 3. [DOI:10.1016/j.blre.2007.05.002]
29. G6PD Deficiency Is Associated with Significant Protection Against Severe, Life-threatening Malaria. Public Library of Science. March 13, 2007. Available from https://www.sciencedaily.com/releases/2007/03/070313114502.htm
30. Al-Allawi N, A Eissa A, Jubrael JMS, AR Jamal S, Hamamy H. Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq. BMC Blood Disord. 2010, 5:10:6. doi: 10.1186/1471-2326-10-6. [DOI:10.1186/1471-2326-10-6]
31. Belsey MA. The epidemiology of favism. Bull World Health Organ. 1973; 48(1):1-13.
32. Alavi naini A. Favism in Mazandaran , north of Iran. Iranian Journal of Public Health. 1997: Vol 26 No 3-4.
33. Kamali M,Taheri Sarvtin M. Investigating the Prevalence of Glucose - 6 -Phosphate Dehydrogenase (G6PD) Deficiency among Patients with Favism Symptoms in Kerman City, Southern Iran. International Journal of Medical Laboratory 2023 ;10 (2):173 -173. [DOI:10.18502/ijml.v10i2.12950]
34. Abolghasemi H, Mehrani H, Amid A. An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates. Clinical Biochemistry. 2004: Volume 37, Issue 3, Pages 241-244. [DOI:10.1016/j.clinbiochem.2003.11.010]
35. Nejadaria M, Mortazavi SM, Kohansal MH .Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Neonates Hospitalized in Pasteur Hospital of Bam, Iran. Medical Laboratory Journal, Mar-Apr, 2020; Vol 14: No 2. [DOI:10.29252/mlj.14.2.9]
36. Darbandi B, Zarezadeh S, Atrkar Roshan Z, Hassanzadeh Rad A, Baghersalimi A, The Efficacy of Vitamin E and Folic acid on the Acute Hemolysis Caused by Glucose-6 phosphate Dehydrogenase, Iran J Ped Hematol Oncol. 2017; Vol 7. No 3, 232-236.
37. Safaei Asl A, Emami S, Baghersalimi A, Darbandi B, Hassanzadeh Rad A, Badeli H. Normal saline, the known but least examined fluid therapy method for preventing heme induced nephropathy in children with glucose 6 phosphate dehydrogenase deficiency: a randomized controlled clinical trial. Pediatr Nephrol. 2023 Feb;38(2):549-555
https://doi.org/10.1007/s00467-022-05594-2 [DOI:10.1007/s00467-022-05594-2.]
38. Jafari-Shakib A, Davoudi-Kiakalayeh A, Pour-Fathollah AA, Jafari-Shakib R, Mohtasham-Amiri Z. Health-related quality of life in beta thalassemia major children in north of Iran. Iranian Journal of Blood and Cancer. 2016; 8(4):108-111.
39. Mohtasham-Amiri Z, Khanaki K, Davoudi-Kiakalayeh A, Rezvani SM, Jafari-Shakib A, Jafari-Shakib R. Analysis of survival in patients with beta-thalassemia major in Guilan Northern Iran. Iranian Journal of Blood and Cancer.2018; 10(3):82-86.
40. Homaie Rad, E, Hajizadeh M, Rezaei S, Reihanian A, Ehsani- Chimeh E, Davoudi- Kiakalayeh A. Utilization and expenditures on traditional and herbal medicines in Iran: 2009-2016. Journal of Herbal Medicine.2021; 25:100414. [DOI:10.1016/j.hermed.2020.100414]
41. Davoudi-Kiakalayeh, A, Dalal, K, Yousefzade-Chabok, S, Jansson, B, Mohammadi, R. Costs related to drowning and near drowning in northern Iran (Guilan province).Ocean and Coastal Management, 2011; 54(3): pp. 250-255. [DOI:10.1016/j.ocecoaman.2010.12.004]
42. Tabari-Khomeiran, R, Ehsani-Chimeh, E, Davoudi Kiakalayeh, A, Homaie Rad, E, Delavari, S. Inequity in the distribution of rural family physicians in Iran: a cross sectional study. International Journal of Human Rights in Healthcare. 2019; 12(4): pp. 258-266. [DOI:10.1108/IJHRH-12-2018-0077]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
- Iranian Journal of Blood and Cancer
- Journal Tel: +989369936116
- Publisher Tel: +982122275917
- Mail: Info@ijbc.ir
